We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2011
Avacta Group is to acquire Aptuscan for £1.5m, in order to expand its proprietary reagents and consumables business, and the deal will be funded by a £5.1m share placing.
GlaxoSmithKline has sold a portfolio of over-the-counter medicines to US-based Prestige Brands for £426m.
Sika Liquid Plastics is to submit plans for a £2.5m 12,500 sq ft chemical coatings research laboratory at its site in Preston.
GlaxoSmithKline has secured a £1.5m Scottish Enterprise grant to expand its research and development facilities in Montrose, with the creation of up to 25 jobs.
Alliance Pharma has acquired the Quinoderm and Ceanel dermatology brands from Ferndale Pharmaceuticals for £1.5m.
EMBL-EBI has won £75m of government funding to set up a biological data centre at the Wellcome Trust Genome Campus in Cambridge, with the creation of up to 200 jobs.
Bostik is to relocate its adhesives warehousing and logistics operation and some of the 350 jobs to a new Stan Robinson Group building in Stafford.
Tissue Regenix of York has raised £25m in a share placing to fund the commercial development of its tissue replacement technology, with the creation of up to 30 jobs.
Sinclair IS Pharma is to acquire Advanced Bio-Technologies, the supplier of Kelo-cote dermatological products, from HealthEdge Investment Partners for £21m.
Yule Catto has sold Uquifa, the manufacturer of pharmaceutical ingredients with 390 staff in Spain and Mexico, to Vivimed Labs for £35m.
UCB of Belgium is to acquire certain drug discovery and development programmes of Manchester-based Lectus Therapeutics for undisclosed terms.
Tata Chemicals Europe has appointed Pochin Construction to build a new 18,000 sq ft headquarters at the Brunner Mond complex in Northwich.
Sinclair IS Pharma has sold its Mysoline prescription-only medicine to Laboratoires SERB of France for £11m.
Brecon Pharmaceuticals has taken 23,000 sq ft of warehouse space at Treforest Industrial Estate in South Wales.
SCM Pharma is to invest £5m in the development of 26,000 sq ft of additional pharmaceutical production space at Newburn in Newcastle over the next three years.
William Sinclair has acquired Yorkshire Horticultural Supplies, the Doncaster-based compost manufacturer, for undisclosed terms.
BOC is planning to build a £20m acetylene manufacturing plant at its site in Stallingborough next year, with the creation of 40 jobs.
Redx Pharma has secured RGF funding of £5.9m to support the development of a cancer research centre in Liverpool, with the creation of up to 250 jobs.
Forza Group is planning to set up a new health supplement products factory in Kent.
Molecular Profiles is to invest up to £9m in the expansion of its Nottingham-based pharmaceuticals business, including a new 30,000 sq ft research facility and 62 jobs.
TG Eakin is to invest £6m in the expansion of its skin protection products in Comber, Co Down, by 2013, with the creation of 25 jobs.
Sirius Minerals has announced a major potash discovery near Whitby in North Yorkshire, and hopes to develop a new mine and create up to 1,000 jobs.
Yule Catto has acquired Quality Polymer, the Malaysian aqueous polymer manufacturer with 30 staff, for £10m.
Unilever is to acquire Concern Kalina, the Russian skin and haircare company with 1,900 staff, for £342m.
Axis-Shield, the medical diagnostics firm with sites in Dundee and Uxbridge, is to be acquired by Alere of the US for £235m.
Life Technologies of the US is considering its site in Renfrewshire as a potential location for a new £25m manufacturing plant.
The Technology Strategy Board has unveiled plans for a new £30m stem cell therapy research centre in south-east England in 2012, in a project supported by Pfizer, GlaxoSmithKline and AstraZeneca.
Medpace is to create six jobs at a new clinical research safety office at the University of Stirling.
Aesica Pharmaceuticals has sold a majority stake in its Northumberland-based drug development business to private equity firm Silverfleet Capital.
Novartis is to set up a new 64,000 sq ft headquarters for its pharmaceuticals business at Watchmoor Park in Camberley next March.
Akzo Nobel has selected Ashington as the preferred location to build a new £100m paints factory by 2014, with the creation of 140 jobs.
MDY Healthcare has sold its Trust William online healthcare products business to the Optima Consumer Health subsidiary of William Ransom for a nominal sum.
Abcam is to acquire Ascent Scientific, the Bristol-based biochemical reagents supplier with 23 staff, for £10m.
AccuNostics has raised £4m to fund the expansion of its Forres-based life sciences business, including the creation of about 30 jobs over the next year.
Itac has acquired Texas Coating Developments from Allied Textiles for undisclosed terms, and will relocate its waterproof coatings business from Rawtenstall to Radcliffe.
Multisol, the Nantwich-based chemicals distributor with 170 staff, has been acquired by Brenntag of Germany for an estimated £112m.
Astellas Pharma has confirmed plans to relocate from Staines to a 90,000 sq ft office at the 2000 Hillswood Drive building in Chertsey later this year.
European Medicines Agency is planning to set up a 250,000 sq ft office at the 25 Churchill Place development in London E14 in 2015.
Onyx Scientific, the Sunderland-based drug discovery firm, has been acquired by Ipca Laboratories of India for about £4.6m.
Lipoxen is to acquire SymbioTec, the German clinical trials firm, for £8.8m.
BASF is to make a "significant" investment in the expansion of capacity at its polyacrylamide beads plant in Bradford, in order to transfer production from the US.
E-Therapeutics is to create about ten jobs at a new biotechnology research facility in Oxford by October.
GlaxoSmithKline has pledged to expand its pharmaceutical manufacturing and research operations in the UK, in response to government tax incentives.
Tomms Pharmacy is setting up a new 11,700 sq ft facility to supply medication to the care sector at Bartley Point in Hook, Hampshire.
Immunodiagnostic Systems is planning to expand the workforce at its Boldon-based life sciences business from 100 to 150 by 2013.
ICON has acquired Firecrest Clinical, the Irish provider of site performance management systems, for undisclosed terms.
Elemis is setting up a new 50,000 sq ft headquarters for its spa and skincare products business at the Poplar Park development in Bristol.
Avacta is to relocate its pharmaceutical testing laboratory and 25 jobs from York to its Thorp Arch site in Wetherby in August.
Merseyside Coatings has been sold out of administration by BDO to a management team, securing 44 jobs at its Widnes-based coatings business.
Teva Pharmaceuticals has won permission to extend its warehouse and clean room at Aston Lane North near Runcorn by 53,000 sq ft.
Astellas Pharma is reported to be considering the relocation of its pharmaceuticals headquarters from Staines to a 90,000 sq ft building in Chertsey.
Akzo Nobel is to build a new £100m paints factory in Northumberland by 2014, but existing production facilities that employ 220 staff in Prudhoe and Slough will close.
Leighs Paints, the Bolton-based industrial paints manufacturer with 260 staff, has been acquired by Sherwin-Williams of the US for undisclosed terms.
Equateq is to expand the 31-strong workforce at its Lewis factory by a third, having won a £35m contract to supply omega oil to Irish pharmaceuticals manufacturer Amarin.
Trygg Pharma of Norway is to acquire Lundbeck's Seal Sands plant on Teesside for £14m, and will bring the site back into production with the creation of an initial 25 jobs.
Redx Pharma is seeking government funding to develop a £39m cancer research centre in Liverpool, with the creation of up to 250 jobs over the next five years.
Bakhu Pharma has completed the acquisition of the former Phoenix Chemicals site at Newbie out of administration, and plans to increase the workforce to 50 over the next year.
AstraZeneca is to sell Astra Tech, its Sweden-based dental products business with 2,200 staff, to Dentsply International for about £1.1bn.
Carr's Milling Industries is to sell Carrs Fertilisers, the fertiliser supplier with sites in Silloth, Invergordon and Montrose, to Origin Enterprises for £19m.
BWA, the Manchester-based supplier of water treatment chemicals with 85 staff, has been acquired by investment management firm Berwind Corporation for £185m.
Crown Paints, the Lancashire-based paints manufacturer with about 1,500 staff, is to be sold by private equity firm Endless to Hempel of Denmark for undisclosed terms.
Akzo Nobel is creating 40 jobs at its new £6m fire protection coatings laboratory in Gateshead.
Lab21 is to acquire Myconostica, the Manchester-based developer of molecular diagnostic products, from Amphion Innovations.
Abcam has acquired MitoSciences, the US provider of mitochondrial research tools with 24 staff, for £3.7m.
EKF Diagnostics is to acquire Stanbio Laboratory, the US medical diagnostic devices firm, for £16m.
Shire Pharmaceuticals is to acquire Advanced BioHealing, the US regenerative medicine firm with 400 staff, for £462m.
Huntsman is to relocate its Teesside-based pigments division and 290 staff to a new site at Wynyard Park, including a 54,000 sq ft office and 31,000 sq ft laboratory.
Elan is to sell Elan Drug Technologies, its drug formulation business, to Alkermes of the US for £590m.
Syntopix Group is to acquire Leeds Skin Centre for Applied Research, the Wetherby-based testing laboratory, for £0.9m.
Manchester Organics has sold a 51% stake in its Runcorn-based chemicals business to Navin Fluorine International of India for £4.3m.
Manesty, the Merseyside-based pharmaceutical equipment manufacturer with 110 staff, has been acquired by Bosch of Germany for undisclosed terms.
A-Gas has raised £70m from the sale of a stake to private equity firm LDC, in order to fund the expansion of its Bristol-based industrial gases and chemicals business.
Binding Site, the Birmingham-based biotechnology company, has been acquired by private equity firm Nordic Capital for undisclosed terms.
RSM Tenon is in negotiations to sell the 154-acre former Phoenix Chemicals site in Annan out of administration to Bakhu Pharma.
Lotte Chemical UK has secured £6.7m of government funding to build a PET manufacturing plant at its Wilton site on Teesside, with the creation of 55 jobs.
Chirotech is looking to increase the 40-strong workforce at its newly-expanded 33,000 sq ft biotechnology facility at Cambridge Science Park.
GlaxoSmithKline is considering sites in Montrose, Irvine and Barnard Castle for the development of a new pharmaceuticals plant, which could create up to 1,000 jobs.
Astex Therapeutics, the Cambridge-based drug discovery firm, has been acquired by SuperGen of the US for up to £75m.
Bio-Analytical Technologies of India is to create ten jobs at its new office at Manchester Science Parks over the next 18 months.
Phlexglobal, the Amersham-based pharmaceutical support services firm with 200 staff, has undergone a management buy-out backed by Inflexion Private Equity for undisclosed terms.
Unilever has sold its Sanex soap and shower gel brand to Colgate-Palmolive for £585m, in order to secure approval for the recent acquisition of part of Sara Lee.
Alliance Pharma has acquired the Ashton & Parsons teething treatment and Anbesol mouth ulcer brands from Reckitt Benckiser for £2.6m.
Randox Laboratories is to invest £16m in the expansion of its biotechnology facilities in Antrim, with the creation of 242 jobs.
Instem Life Science Systems has acquired BioWisdom, the Cambridge-based drug discovery firm with 13 staff, for an initial £0.9m.
MSD Biologics, the Billingham-based biotechnology firm with 480 staff, is to be acquired by Fujifilm of Japan, as part of a £300m deal that also includes US-based Diosynth RTP.
Aesica Pharmaceuticals has acquired three manufacturing sites in Germany and Italy from UCB.
Genzyme, the pharmaceuticals firm with 300 staff in Haverhill, has been acquired by Sanofi-Aventis of France for £12bn.
ProStrakan, the Galashiels-based pharmaceuticals firm with 300 staff, is to be acquired by Kyowa Hakko Kirin Co of Japan for £292m.
Trimega is to create ten jobs at its new £1m drug and alcohol testing laboratory in Manchester this year.
Wells Plastics, the Staffordshire-based additives manufacturer, has undergone a £3.8m management buy-out backed by Key Capital Partners.
NextPharma Technologies, the Surrey-based provider of services to the pharmaceutical sector, has been acquired by Sun Capital Partners.
Sinclair Pharma and IS Pharma are in merger discussions that would lead to the creation of a pan-European speciality pharmaceuticals group called Sinclair IS Pharma.
Tennants Consolidated has acquired Tessenderlo Fine Chemicals of Leek for £17m.
CM&D Pharma, the London-based medical gums supplier, has been acquired by Nestle for undisclosed terms.
Solvert is looking to set up a £100m factory to convert organic waste into chemicals on Teesside by 2015, with the creation of up to 80 jobs.
Oxford BioMedica is to acquire a 16,000 sq ft manufacturing facility in Oxford from RecipharmCobra Biologics for £1.9m, with the creation of up to 40 jobs.
Angel Biotechnology has raised £1.9m in a share placing to fund the reopening of its manufacturing plant in Newcastle, with the creation of up to ten jobs.
Aesica is planning to double the size of its R5 Pharmaceuticals factory and laboratory business at BioCity Nottingham, with the creation of up to 30 jobs.
PRA, the clinical research firm, is said to be in negotiations to set up a 43,000 sq ft office at Green Park in Reading.
Waters Corporation is planning to relocate its research business and 513 staff from four sites to a new £60m headquarters and laboratory in Wilmslow in 2013, with the creation of 100 new jobs.
LGC has sold its chemical characterisation division in Runcorn to SGS, with the transfer of eight staff.
J&H Bunn, the Great Yarmouth-based fertiliser supplier with 150 staff at 12 sites, is to be acquired by Koch Fertilizer for undisclosed terms.
Soapworks, the Glasgow-based soap manufacturer with 100 staff, has undergone a management buy-out from L'Oreal of France for undisclosed terms.
Sigma Pharmaceuticals has acquired four new warehouse units totalling 40,910 sq ft at the Watford Business Park.